Advertisements


Spero Therapeutics, Inc. (SPRO) Reports Q3 Loss

Spero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of 6.25% and 0.00%, respectively, f.....»»

Category: personnelSource: nytNov 8th, 2018

Cytori Therapeutics (CYTX) Reports Q3 Loss, Misses Revenue Estimates

Zacks.....»»

Category: topSource: redinewsNov 15th, 2018

Cytori Therapeutics (CYTX) Reports Q3 Loss, Misses Revenue Estimates

Cytori (CYTX) delivered earnings and revenue s.....»»

Category: dealsSource: nytNov 14th, 2018

Entasis Therapeutics reports Q3 net loss ($8.5M) vs. ($8.3M) last year

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 14th, 2018

Capricor Therapeutics (CAPR) Reports Q3 Loss, Lags Revenue Estimates

Zacks.....»»

Category: topSource: redinewsNov 14th, 2018

Jounce Therapeutics, Inc. (JNCE) Reports Q3 Loss, Tops Revenue Estimates

Zacks.....»»

Category: topSource: redinewsNov 13th, 2018

VTv Therapeutics (VTVT) Reports Q3 Loss, Tops Revenue Estimates

vTv Therapeutics (VTVT) delivered earnings and revenue surprises of 60.00% and 63......»»

Category: personnelSource: nytNov 8th, 2018

Flexion Therapeutics (FLXN) Reports Q3 Loss, Tops Revenue Estimates

Flexion Therapeutics (F.....»»

Category: personnelSource: nytNov 7th, 2018

Fate Therapeutics (FATE) Reports Q3 Loss, Lags Revenue Estimates

Fate Therapeutics (FATE) delivered earnings and revenue surprises of -29.17% and -72.98%, respectively, for the quarter ended September 2018.....»»

Category: personnelSource: nytNov 1st, 2018

Arcturus Therapeutics (ARCT) Reports Q2 Loss, Lags Revenue Estimates

Zacks.....»»

Category: topSource: redinewsOct 1st, 2018

Oversold Conditions For Spero Therapeutics (SPRO)

Dividend Channel.....»»

Category: topSource: redinewsSep 13th, 2018

Rancho Cordova"s Cesca Therapeutics reports $27.2 million loss on impairment of assets

Cesca Therapeutics Inc., a Rancho Cordova-based cell therapy company, said it incurred $27.2 million in charges against earnings last quarter for impairment in the value of assets. The impairment charges include $12.7 million to goodwill and $14.5.....»»

Category: topSource: bizjournalsAug 13th, 2018

Abeona Therapeutics (ABEO) Reports Q2 Loss, Lags Revenue Estimates

Abeona Therapeutics (ABEO) delivered earnings and revenue surprises of -56.25% and -54.....»»

Category: worldSource: nytAug 9th, 2018

Spero Therapeutics reports Q2 EPS (69c), consensus (78c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 9th, 2018

CytomX Therapeutics (CTMX) Reports Q2 Loss, Tops Revenue Estimates

CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of -2.94% and 29.52%, respecti.....»»

Category: personnelSource: nytAug 8th, 2018

Sarepta Therapeutics (SRPT) Reports Q2 Loss, Tops Revenue Estimates

Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of 8.51% and 3.66%, respectively, for the .....»»

Category: smallbizSource: nytAug 8th, 2018

Insys Therapeutics (INSY) Reports Q2 Loss, Lags Revenue Estimates

Insys Therapeutics (INSY) delivered earnings .....»»

Category: smallbizSource: nytAug 8th, 2018

Neos Therapeutics (NEOS) Reports Q2 Loss, Lags Revenue Estimates

Neos Therapeutics (NEOS) delivered earnings and revenue surprises of -20.93% and -4.51%, respectiv.....»»

Category: worldSource: nytAug 8th, 2018

Flexion Therapeutics (FLXN) Reports Q2 Loss, Lags Revenue Estimates

Flexion Therapeutics (FLXN) d.....»»

Category: worldSource: nytAug 7th, 2018

PTC Therapeutics (PTCT) Reports Q2 Loss, Misses Revenue Estimates

PTC Therapeutics (PTCT) delivered earnings and revenue surp.....»»

Category: personnelSource: nytAug 7th, 2018

Spero Therapeutics reports Q1 EPS (74c), consensus ($1.20)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 10th, 2018